Stay updated on BIO89-100 Multiple Dose in NASH Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.

Latest updates to the BIO89-100 Multiple Dose in NASH Clinical Trial page
- Check3 days agoChange DetectedThe Locations section was reorganized to consolidate state locations under a single Locations section, replacing individual state location subsections; revision updated from v3.3.2 to v3.3.3.SummaryDifference1.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPublications section updated to note that PubMed-fetched publications are auto-filled and may not all pertain to the study. The old PubMed-generated publication description was removed and revision identifiers updated to v3.3.2 and v3.2.0.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page removed a government funding/operating status notice; no study content or data changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedThe screenshots show only layout and styling adjustments; core study information such as eligibility criteria, enrollment numbers, and location lists appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check76 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference3%

- Check83 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

Stay in the know with updates to BIO89-100 Multiple Dose in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.